跳至主要内容
临床试验/DRKS00010625
DRKS00010625已完成未知

Acupuncture for chemotherapy-induced peripheral neuropathy (CIPN) - ACUCI

HanseMerkur Versicherungsgesellschaft0 个研究点目标入组 60 人开始时间: 2016年6月23日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Clinically diagnosed chemotherapy-induced peripheral neuropathy, pathologic results of the sural nerve in nerve conduction studies

排除标准

  • Current chemotherapy treatment or restart of chemotherapy due to tumor recurrence; Other diseases hat may cause peripheral neuropathy;
  • History of epilepsy;
  • Coagulopathy or use of anticoagulants with bleeding time > 3 min, prothrombin time < 40%, platelet count < 50.000/µl or PTT > 50 sec;
  • Bacterial infection or other skin diseases at the lower extremities;
  • Bone fracture of the lower extremities during the last three months;
  • Alcohol, opiat, analgetic, or drug abuse;
  • Psychiatric illnesses other than mild depression;
  • Incapacity of following the study instructions ;(severe language disturbances, serious cognitive deficits, lack of time);
  • Pregnant or breast-feeding women;
  • Current participation in other clinical studies.

研究者

发起方
HanseMerkur Versicherungsgesellschaft

相似试验